chr15-88860173-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369268.1(ACAN):​c.6833-153G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 150,454 control chromosomes in the GnomAD database, including 2,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 2578 hom., cov: 29)

Consequence

ACAN
NM_001369268.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0650

Publications

5 publications found
Variant links:
Genes affected
ACAN (HGNC:319): (aggrecan) This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008]
ACAN Gene-Disease associations (from GenCC):
  • osteochondritis dissecans
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • spondyloepiphyseal dysplasia, Kimberley type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • spondyloepimetaphyseal dysplasia, aggrecan type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • short stature-advanced bone age-early-onset osteoarthritis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 15-88860173-G-A is Benign according to our data. Variant chr15-88860173-G-A is described in ClinVar as Benign. ClinVar VariationId is 1242446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.338 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACANNM_001369268.1 linkc.6833-153G>A intron_variant Intron 12 of 18 ENST00000560601.4 NP_001356197.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACANENST00000560601.4 linkc.6833-153G>A intron_variant Intron 12 of 18 3 NM_001369268.1 ENSP00000453581.2 H0YMF1

Frequencies

GnomAD3 genomes
AF:
0.129
AC:
19377
AN:
150346
Hom.:
2558
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.343
Gnomad AMI
AF:
0.0407
Gnomad AMR
AF:
0.0941
Gnomad ASJ
AF:
0.0546
Gnomad EAS
AF:
0.124
Gnomad SAS
AF:
0.0657
Gnomad FIN
AF:
0.0341
Gnomad MID
AF:
0.106
Gnomad NFE
AF:
0.0347
Gnomad OTH
AF:
0.109
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.129
AC:
19437
AN:
150454
Hom.:
2578
Cov.:
29
AF XY:
0.128
AC XY:
9400
AN XY:
73452
show subpopulations
African (AFR)
AF:
0.343
AC:
13871
AN:
40434
American (AMR)
AF:
0.0947
AC:
1435
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.0546
AC:
189
AN:
3462
East Asian (EAS)
AF:
0.125
AC:
637
AN:
5114
South Asian (SAS)
AF:
0.0641
AC:
303
AN:
4724
European-Finnish (FIN)
AF:
0.0341
AC:
355
AN:
10424
Middle Eastern (MID)
AF:
0.0972
AC:
28
AN:
288
European-Non Finnish (NFE)
AF:
0.0347
AC:
2352
AN:
67846
Other (OTH)
AF:
0.110
AC:
230
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
650
1300
1949
2599
3249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0680
Hom.:
1101
Bravo
AF:
0.148
Asia WGS
AF:
0.103
AC:
360
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.5
DANN
Benign
0.79
PhyloP100
-0.065
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3784757; hg19: chr15-89403404; COSMIC: COSV61357583; API